This conserved lipid acyltransferase has many re-entrant segments but only one true TM helix. Most closely related to bacterial acyltransferases.. Heavily expanded in kinetoplastids for unknown reasons. Localization: ER (by homology)
Phospholipid biosynthesis, Acyltransferase-like , copy 2
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Cuervo et al. | no | yes: 0 | 
| Hassani et al. | no | yes: 0 | 
| Forrest at al. (metacyclic) | no | yes: 0 | 
| Forrest at al. (procyclic) | no | yes: 0 | 
| Silverman et al. | no | yes: 0 | 
| Pissara et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Pires et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Silverman et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Jamdhade et al. | yes | yes: 27 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 29 | 
| NetGPI | no | yes: 0, no: 29 | 
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0016020 | membrane | 2 | 25 | 
| GO:0110165 | cellular anatomical entity | 1 | 25 | 
Related structures:
AlphaFold database: A0A3S7WNW6
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0006629 | lipid metabolic process | 3 | 5 | 
| GO:0006644 | phospholipid metabolic process | 4 | 5 | 
| GO:0006650 | glycerophospholipid metabolic process | 5 | 5 | 
| GO:0006654 | phosphatidic acid biosynthetic process | 6 | 5 | 
| GO:0006793 | phosphorus metabolic process | 3 | 5 | 
| GO:0006796 | phosphate-containing compound metabolic process | 4 | 5 | 
| GO:0008152 | metabolic process | 1 | 5 | 
| GO:0008610 | lipid biosynthetic process | 4 | 5 | 
| GO:0008654 | phospholipid biosynthetic process | 5 | 5 | 
| GO:0009058 | biosynthetic process | 2 | 5 | 
| GO:0009987 | cellular process | 1 | 5 | 
| GO:0019637 | organophosphate metabolic process | 3 | 5 | 
| GO:0044237 | cellular metabolic process | 2 | 5 | 
| GO:0044238 | primary metabolic process | 2 | 5 | 
| GO:0044249 | cellular biosynthetic process | 3 | 5 | 
| GO:0044255 | cellular lipid metabolic process | 3 | 5 | 
| GO:0045017 | glycerolipid biosynthetic process | 4 | 5 | 
| GO:0046473 | phosphatidic acid metabolic process | 6 | 5 | 
| GO:0046474 | glycerophospholipid biosynthetic process | 5 | 5 | 
| GO:0046486 | glycerolipid metabolic process | 4 | 5 | 
| GO:0071704 | organic substance metabolic process | 2 | 5 | 
| GO:0090407 | organophosphate biosynthetic process | 4 | 5 | 
| GO:1901576 | organic substance biosynthetic process | 3 | 5 | 
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0003824 | catalytic activity | 1 | 30 | 
| GO:0016740 | transferase activity | 2 | 30 | 
| GO:0016746 | acyltransferase activity | 3 | 30 | 
| GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity | 7 | 7 | 
| GO:0008374 | O-acyltransferase activity | 5 | 7 | 
| GO:0016411 | acylglycerol O-acyltransferase activity | 6 | 7 | 
| GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 7 | 
| GO:0042171 | lysophosphatidic acid acyltransferase activity | 6 | 7 | 
| GO:0071617 | lysophospholipid acyltransferase activity | 5 | 7 | 
| Leishmania | From | To | Domain/Motif | Score | 
|---|---|---|---|---|
| CLV_MEL_PAP_1 | 175 | 181 | PF00089 | 0.526 | 
| CLV_NRD_NRD_1 | 166 | 168 | PF00675 | 0.515 | 
| CLV_NRD_NRD_1 | 324 | 326 | PF00675 | 0.647 | 
| CLV_NRD_NRD_1 | 81 | 83 | PF00675 | 0.294 | 
| CLV_PCSK_FUR_1 | 320 | 324 | PF00082 | 0.588 | 
| CLV_PCSK_KEX2_1 | 320 | 322 | PF00082 | 0.654 | 
| CLV_PCSK_KEX2_1 | 323 | 325 | PF00082 | 0.682 | 
| CLV_PCSK_KEX2_1 | 81 | 83 | PF00082 | 0.279 | 
| CLV_PCSK_PC7_1 | 320 | 326 | PF00082 | 0.623 | 
| CLV_PCSK_SKI1_1 | 333 | 337 | PF00082 | 0.765 | 
| CLV_PCSK_SKI1_1 | 51 | 55 | PF00082 | 0.351 | 
| DOC_CYCLIN_yCln2_LP_2 | 70 | 76 | PF00134 | 0.415 | 
| DOC_MAPK_gen_1 | 248 | 257 | PF00069 | 0.314 | 
| DOC_MAPK_gen_1 | 81 | 89 | PF00069 | 0.514 | 
| DOC_MAPK_MEF2A_6 | 293 | 301 | PF00069 | 0.395 | 
| DOC_MAPK_MEF2A_6 | 82 | 91 | PF00069 | 0.523 | 
| DOC_PP1_RVXF_1 | 95 | 102 | PF00149 | 0.375 | 
| DOC_PP2B_LxvP_1 | 60 | 63 | PF13499 | 0.405 | 
| DOC_PP2B_LxvP_1 | 77 | 80 | PF13499 | 0.568 | 
| DOC_USP7_MATH_1 | 202 | 206 | PF00917 | 0.202 | 
| DOC_WW_Pin1_4 | 147 | 152 | PF00397 | 0.317 | 
| DOC_WW_Pin1_4 | 226 | 231 | PF00397 | 0.265 | 
| LIG_14-3-3_CterR_2 | 353 | 356 | PF00244 | 0.431 | 
| LIG_Actin_WH2_2 | 151 | 169 | PF00022 | 0.345 | 
| LIG_AP2alpha_1 | 140 | 144 | PF02296 | 0.261 | 
| LIG_BRCT_BRCA1_1 | 216 | 220 | PF00533 | 0.324 | 
| LIG_CSL_BTD_1 | 262 | 265 | PF09270 | 0.369 | 
| LIG_FHA_1 | 335 | 341 | PF00498 | 0.421 | 
| LIG_FHA_1 | 56 | 62 | PF00498 | 0.319 | 
| LIG_FHA_2 | 241 | 247 | PF00498 | 0.256 | 
| LIG_FHA_2 | 343 | 349 | PF00498 | 0.403 | 
| LIG_GBD_Chelix_1 | 295 | 303 | PF00786 | 0.547 | 
| LIG_LIR_Gen_1 | 138 | 149 | PF02991 | 0.269 | 
| LIG_LIR_Gen_1 | 240 | 249 | PF02991 | 0.246 | 
| LIG_LIR_Gen_1 | 34 | 44 | PF02991 | 0.467 | 
| LIG_LIR_Nem_3 | 138 | 144 | PF02991 | 0.292 | 
| LIG_LIR_Nem_3 | 240 | 244 | PF02991 | 0.263 | 
| LIG_LIR_Nem_3 | 34 | 39 | PF02991 | 0.470 | 
| LIG_Pex14_2 | 140 | 144 | PF04695 | 0.264 | 
| LIG_Pex14_2 | 172 | 176 | PF04695 | 0.312 | 
| LIG_Pex14_2 | 182 | 186 | PF04695 | 0.282 | 
| LIG_Pex14_2 | 92 | 96 | PF04695 | 0.377 | 
| LIG_SH2_CRK | 36 | 40 | PF00017 | 0.311 | 
| LIG_SH2_STAT5 | 253 | 256 | PF00017 | 0.285 | 
| LIG_SH2_STAT5 | 36 | 39 | PF00017 | 0.285 | 
| LIG_SH2_STAT5 | 69 | 72 | PF00017 | 0.372 | 
| LIG_SH2_STAT5 | 76 | 79 | PF00017 | 0.576 | 
| LIG_SUMO_SIM_par_1 | 253 | 260 | PF11976 | 0.364 | 
| LIG_TRAF2_1 | 316 | 319 | PF00917 | 0.322 | 
| LIG_TYR_ITIM | 74 | 79 | PF00017 | 0.469 | 
| LIG_UBA3_1 | 155 | 163 | PF00899 | 0.202 | 
| LIG_WRC_WIRS_1 | 238 | 243 | PF05994 | 0.279 | 
| LIG_WW_3 | 263 | 267 | PF00397 | 0.281 | 
| MOD_CK1_1 | 256 | 262 | PF00069 | 0.406 | 
| MOD_CK2_1 | 240 | 246 | PF00069 | 0.302 | 
| MOD_CK2_1 | 342 | 348 | PF00069 | 0.404 | 
| MOD_GlcNHglycan | 187 | 190 | PF01048 | 0.588 | 
| MOD_GlcNHglycan | 64 | 67 | PF01048 | 0.327 | 
| MOD_GSK3_1 | 131 | 138 | PF00069 | 0.237 | 
| MOD_GSK3_1 | 157 | 164 | PF00069 | 0.308 | 
| MOD_N-GLC_1 | 135 | 140 | PF02516 | 0.471 | 
| MOD_N-GLC_1 | 226 | 231 | PF02516 | 0.466 | 
| MOD_NEK2_1 | 135 | 140 | PF00069 | 0.248 | 
| MOD_NEK2_1 | 161 | 166 | PF00069 | 0.296 | 
| MOD_NEK2_1 | 214 | 219 | PF00069 | 0.304 | 
| MOD_NEK2_1 | 53 | 58 | PF00069 | 0.324 | 
| MOD_NMyristoyl | 1 | 7 | PF02799 | 0.526 | 
| MOD_PIKK_1 | 202 | 208 | PF00454 | 0.202 | 
| MOD_PKA_2 | 288 | 294 | PF00069 | 0.284 | 
| MOD_Plk_1 | 135 | 141 | PF00069 | 0.271 | 
| MOD_Plk_1 | 259 | 265 | PF00069 | 0.354 | 
| MOD_Plk_4 | 136 | 142 | PF00069 | 0.262 | 
| MOD_Plk_4 | 240 | 246 | PF00069 | 0.317 | 
| MOD_Plk_4 | 34 | 40 | PF00069 | 0.461 | 
| MOD_ProDKin_1 | 147 | 153 | PF00069 | 0.317 | 
| MOD_ProDKin_1 | 226 | 232 | PF00069 | 0.265 | 
| MOD_SUMO_rev_2 | 330 | 335 | PF00179 | 0.447 | 
| TRG_ENDOCYTIC_2 | 238 | 241 | PF00928 | 0.301 | 
| TRG_ENDOCYTIC_2 | 252 | 255 | PF00928 | 0.263 | 
| TRG_ENDOCYTIC_2 | 36 | 39 | PF00928 | 0.353 | 
| TRG_ENDOCYTIC_2 | 76 | 79 | PF00928 | 0.475 | 
| TRG_ER_diArg_1 | 248 | 251 | PF00400 | 0.314 | 
| TRG_ER_diArg_1 | 320 | 323 | PF00400 | 0.452 | 
| TRG_ER_diArg_1 | 39 | 42 | PF00400 | 0.383 | 
| TRG_ER_diArg_1 | 80 | 82 | PF00400 | 0.543 | 
| Protein | Taxonomy | Sequence identity | Coverage | 
|---|---|---|---|
| A0A0N0P455 | Leptomonas seymouri | 64% | 100% | 
| A0A0N1HTP4 | Leptomonas seymouri | 53% | 100% | 
| A0A0N1I6V1 | Leptomonas seymouri | 34% | 100% | 
| A0A0N1IKX5 | Leptomonas seymouri | 33% | 100% | 
| A0A0S4IQ05 | Bodo saltans | 32% | 100% | 
| A0A0S4IR22 | Bodo saltans | 41% | 100% | 
| A0A1X0P9F0 | Trypanosomatidae | 34% | 100% | 
| A0A3R7NKA0 | Trypanosoma rangeli | 34% | 100% | 
| A0A3S5H5E4 | Leishmania donovani | 50% | 100% | 
| A0A3S5H7L8 | Leishmania donovani | 33% | 100% | 
| A4H419 | Leishmania braziliensis | 56% | 100% | 
| A4H420 | Leishmania braziliensis | 70% | 100% | 
| A4HHM7 | Leishmania braziliensis | 33% | 100% | 
| A4HKI5 | Leishmania braziliensis | 29% | 100% | 
| A4HSA1 | Leishmania infantum | 52% | 100% | 
| A4HSA2 | Leishmania infantum | 100% | 100% | 
| A4I4U1 | Leishmania infantum | 32% | 100% | 
| A4I4U2 | Leishmania infantum | 34% | 100% | 
| C9ZLI8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 33% | 100% | 
| E9AE89 | Leishmania major | 32% | 100% | 
| E9AE90 | Leishmania major | 33% | 100% | 
| E9AK86 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 87% | 100% | 
| E9ALJ6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 33% | 100% | 
| E9B2X4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 100% | 
| Q4Q582 | Leishmania major | 28% | 100% | 
| Q9NF90 | Leishmania major | 92% | 100% | 
| Q9NF91 | Leishmania major | 51% | 100% | 
| V5C201 | Trypanosoma cruzi | 35% | 100% |